Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatocellular carcinoma
Symptom |hepatitis c
Sentences 114
PubMedID- 24223115 The progression of hepatic fibrosis is an important predictive factor for the development of lc and hepatocellular carcinoma not only in patients with chronic hepatitis c, but also in those with nash 4.
PubMedID- 26070204 Serum wisteria floribunda agglutinin-positive mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis c after sustained virological response.
PubMedID- 22066022 Serum microrna-21 as marker for necroinflammation in hepatitis c patients with and without hepatocellular carcinoma.
PubMedID- 21319193 Liver stiffness measurement (lsm) using fibroscan accurately assesses the degree of liver fibrosis and the risk of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c.
PubMedID- 21610221 Background: this study explores the influence of two functional genetic polymorphisms in the regulated on activation in normal t-cell expressed and secreted(rantes) promoter on the risk of hepatocellular carcinoma (hcc) occurrence in patients with alcoholic or hepatitis c virus (hcv)-related cirrhosis.
PubMedID- 20981260 A 73-year-old man with a history of hepatocellular carcinoma associated with hepatitis c virus-related cirrhosis was referred to the department of urology because a thickened wall of the urinary bladder was incidentally detected by computed tomography (ct).
PubMedID- 24179611 Chemoprevention of hepatocellular carcinoma in patients with hepatitis c virus related cirrhosis.
PubMedID- 23564522 The effects of interferon (ifn) treatment and the post-ifn treatment alpha-fetoprotein (afp) levels on risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc) are unknown.
PubMedID- 21526141 We report a case of hepatocellular carcinoma (hcc) with chronic hepatitis c virus infection successfully treated with percutaneous radiofrequency ablation (rfa) under live four-dimensional (4d) echo guidance.
PubMedID- 24463696 Influence of human t-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 22439008 stated that phlebotomy therapy may potentially lower the risk of progression to hepatocellular carcinoma (hcc) in patients with hepatitis c virus infection.
PubMedID- 25743000 Objective: to determine the impact of phlebotomy on the laboratory values and the incidence of hepatocellular carcinoma (hcc) in patients with hepatitis c.
PubMedID- 24081938 Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis c virus infection: further evidence is warranted.
PubMedID- 25650331 Purpose: to evaluate whether a hepatic fibrosis index (hfi), quantified on the basis of hepatic contour abnormality, is a risk factor for the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c.

Page: 1 2 3